Table: Wakamoto Pharm - 9-MTH parent results

Wakamoto Pharmaceutical

02/02/2018 06:00

Feb 2 (Reuters)-  
             Wakamoto Pharmaceutical Co Ltd  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended       Year to  
                Dec 31, 2017        Dec 31, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             8.39                8.34             10.93     
                 (+0.6 pct)          (-2.7 pct)       (+0.9 pct)   
  Operating         7 mln              70 mln           100 mln    
                 (-90.0 pct)         (-68.0 pct)      (+14.5 pct)  
  Recurring        29 mln              113 mln          80 mln     
                 (-74.0 pct)         (-59.7 pct)      (-22.3 pct)  
  Net              13 mln              73 mln           30 mln     
                 (-82.3 pct)         (-56.3 pct)      (-68.3 pct)  
  EPS             0.38 yen            2.12 yen         0.86 yen    
  Ann Div                             3.00 yen                     
  -Q2 div            NIL                 NIL                       
  -Q4 div                             3.00 yen                     
   
  NOTE - Wakamoto Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T  
  ((Tokyo Headline News Desk +813 6441 1812))